These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 7737628)

  • 1. Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis).
    Wanless IR; Liu JJ; Butany J
    Hepatology; 1995 May; 21(5):1232-7. PubMed ID: 7737628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathology of the liver in Budd-Chiari syndrome: portal vein thrombosis and the histogenesis of veno-centric cirrhosis, veno-portal cirrhosis, and large regenerative nodules.
    Tanaka M; Wanless IR
    Hepatology; 1998 Feb; 27(2):488-96. PubMed ID: 9462648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension.
    Wanless IR; Wong F; Blendis LM; Greig P; Heathcote EJ; Levy G
    Hepatology; 1995 May; 21(5):1238-47. PubMed ID: 7737629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrous obliterative lesions of veins contribute to progressive fibrosis in chronic liver allograft rejection.
    Nakazawa Y; Jonsson JR; Walker NI; Kerlin P; Steadman C; Lynch SV; Strong RW; Clouston AD
    Hepatology; 2000 Dec; 32(6):1240-7. PubMed ID: 11093730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of granulomatous phlebitis and thrombosis in the pathogenesis of cirrhosis and portal hypertension in sarcoidosis.
    Moreno-Merlo F; Wanless IR; Shimamatsu K; Sherman M; Greig P; Chiasson D
    Hepatology; 1997 Sep; 26(3):554-60. PubMed ID: 9303482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological aspects of diffuse nodular hyperplasia of the liver.
    Weinbren K; Mutum SS
    J Pathol; 1984 Jun; 143(2):81-92. PubMed ID: 6737120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of ischemia in causing apoptosis, atrophy, and nodular hyperplasia in human liver.
    Shimamatsu K; Wanless IR
    Hepatology; 1997 Aug; 26(2):343-50. PubMed ID: 9252144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cirrhosis of vascular origin].
    Valla D
    Rev Prat; 1991 May; 41(13):1170-3. PubMed ID: 2063118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hepatic microcirculation in the isolated perfused human liver.
    Villeneuve JP; Dagenais M; Huet PM; Roy A; Lapointe R; Marleau D
    Hepatology; 1996 Jan; 23(1):24-31. PubMed ID: 8550044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and acquired thrombotic factors in chronic hepatitis C.
    Poujol-Robert A; Rosmorduc O; Serfaty L; Coulet F; Poupon R; Robert A
    Am J Gastroenterol; 2004 Mar; 99(3):527-31. PubMed ID: 15056097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital hepatic fibrosis: evolving morphology.
    Bernstein J; Stickler GB; Neel IV
    APMIS Suppl; 1988; 4():17-26. PubMed ID: 3224022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of central perivenulitis in pediatric liver transplantation.
    Abraham SC; Freese DK; Ishitani MB; Krasinskas AM; Wu TT
    Am J Surg Pathol; 2008 Oct; 32(10):1479-88. PubMed ID: 18708942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis.
    Wanless IR; Shiota K
    Semin Liver Dis; 2004 Feb; 24(1):99-106. PubMed ID: 15085490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenic Doppler impedance indices: influence of different portal hemodynamic conditions.
    Bolognesi M; Sacerdoti D; Merkel C; Gerunda G; Maffei-Faccioli A; Angeli P; Jemmolo RM; Bombonato G; Gatta A
    Hepatology; 1996 May; 23(5):1035-40. PubMed ID: 8621130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occlusive venous lesions in alcoholic liver disease. A study of 200 cases.
    Goodman ZD; Ishak KG
    Gastroenterology; 1982 Oct; 83(4):786-96. PubMed ID: 7106509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrahepatic portal venopathy and related disorders of the liver.
    Chawla Y; Dhiman RK
    Semin Liver Dis; 2008 Aug; 28(3):270-81. PubMed ID: 18814080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy.
    Abraham SC; Kamath PS; Eghtesad B; Demetris AJ; Krasinskas AM
    Am J Surg Pathol; 2006 Nov; 30(11):1454-61. PubMed ID: 17063088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Portal vein and hepatic vein thrombosis in occult myeloproliferative syndrome. Progression of thrombosis under heparin therapy].
    Frey HR; Suter B
    Schweiz Med Wochenschr; 1996 Aug; 126(34):1437-41. PubMed ID: 8848706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sinusoidal and postsinusoidal vascular systems in liver cirrhosis.
    Schäfer K; Bassermann R; Ringel K
    Hepatogastroenterology; 1981 Oct; 28(5):236-9. PubMed ID: 7345006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic localization of endothelin-1 in patients with idiopathic portal hypertension and cirrhosis of the liver.
    Kamath PS; Carpenter HA; Lloyd RV; McKusick MA; Steers JL; Nagorney DM; Miller VM
    Liver Transpl; 2000 Sep; 6(5):596-602. PubMed ID: 10980059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.